Bipolar Proteomic Assay Validation Study

CompletedOBSERVATIONAL
Enrollment

261

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 8, 2018

Study Completion Date

November 8, 2018

Conditions
Major Depressive Disorder, Bipolar I and Bipolar II
Interventions
OTHER

Diagnostic test (LDT)

Proteomic assay

Trial Locations (5)

15213

University of Pittsburgh Western Psychiatric Institute and Clinic, Pittsburgh

45040

Lindner Center of HOPE/University of Cincinnati College of Medicine, Mason

52242

University of Iowa Health Care, Department of Psychiatry, Iowa City

55414

University of Minnesota (UMN) Department of Psychiatry, Minneapolis

78229

University of Texas Health Science Center, San Antonio

All Listed Sponsors
collaborator

University of Minnesota

OTHER

lead

Myriad Genetic Laboratories, Inc.

INDUSTRY

NCT02746367 - Bipolar Proteomic Assay Validation Study | Biotech Hunter | Biotech Hunter